Keywords: fda, clears, genzyme, biomarin, drug, mps, food
FDA clears Genzyme, BioMarin drug for MPS
Article | 12 May 2003
The US Food and Drug Administration has given marketing approval forAldurazyme (laronidase), a drug for the treatment of mucopolysaccharidosis-1, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
